Petros Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $725 | $1,576 | $1,421 | $1,388 |
Gross Profit | 460 | 1,289 | 1,092 | 1,056 |
EBITDA | -8,438 | -1,293 | 207 | -1,288 |
EBIT | -9,105 | -2,061 | -547 | -2,042 |
Net Income | -9,273 | -2,220 | -662 | -8,026 |
Net Change In Cash | 725 | 1,576 | 1,421 | 1,388 |
Free Cash Flow | 959 | -790 | -1,662 | -1,134 |
Cash | 3,709 | 3,894 | 7,460 | 11,080 |
Basic Shares | 11,319 | 9,829 | 7,388 | 4,756 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $5,112,043 | $5,822 | $5,992 | $7,811 |
Gross Profit | 3,899,343 | 4,191 | 3,702 | 6,211 |
EBITDA | -12,048,480 | -4,211 | -13,725 | -1,636 |
EBIT | -14,879,699 | -7,627 | -19,441 | -8,618 |
Net Income | -14,318 | -8,163 | -27,037 | -9,355 |
Net Change In Cash | 5,112,043 | 5,822 | 5,992 | 7,811 |
Free Cash Flow | -2,603,051 | -7,626 | -12,797 | -11,862 |
Cash | 3,709 | 13,336 | 9,426 | 23,847 |
Basic Shares | 80,260 | 2,176 | 2,070 | 1,088 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.02 |
2024-09-30 | -$0.53 |
2024-06-30 | -$0.37 |
2024-03-31 | -$1.69 |
